Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Kidney Neoplasms × Naltrexone × 1 year × Clear all

Sponsor

Conditions

Skin Neoplasms 1 Prostatic Neoplasms 1 Obesity 1 Metabolic Syndrome 1 Melanoma 1 Inflammation 1 Dyslipidemias 1

Interventions

pembrolizumab 14 Nivolumab 12 Ipilimumab 9 cabozantinib 6 Axitinib 6 belzutifan 5 Radiosurgery 5 atezolizumab 4 Sunitinib 3 Radiotherapy 3 Biopsy 3 zimberelimab 2 palbociclib 2 lenvatinib 2 Surveys and Questionnaires 2 Pluvicto 2 Magnetic Resonance Spectroscopy 2 Everolimus 2 2-(3-(1-carboxy-5-((6-fluoropyridine-3-carbonyl)amino)pentyl)ureido)pentanedioic acid 2 trebananib 1 toripalimab 1 tocilizumab 1 temsirolimus 1 talazoparib 1 spartalizumab 1 seribantumab 1 polyethylene glycol 3350 1 pazopanib 1 guadecitabine 1 gallium Ga 68 dotatate 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡